We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF

220 hedge funds and large institutions have $528M invested in ARK Genomic Revolution ETF in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 40 increasing their positions, 69 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 33

0% more funds holding

Funds holding: 220 → 220 (0)

7% less call options, than puts

Call options by funds: $107M | Put options by funds: $116M

2.28% less ownership

Funds ownership: 53.16% → 50.88% (-2.3%)

35% less capital inflows, than outflows

Capital inflows: $59.6M | Capital outflows: $91.7M

42% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 69

Holders
220
Holders Change
–
Holders Change %
0%
% of All Funds
2.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
40
Reduced
69
Closed
33
Calls
$107M
Puts
$116M
Net Calls
-$8.28M
Net Calls Change
-$21M

ARKG Hedge Fund Activity: Q2 2025 in Review

220 of the 7,633 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2025, worth a combined $528M — up 9.5% from $482M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ARKG positions and 33 closed out — a net gain of 3 holders — while 40 added to existing stakes and 69 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $20.2M. The largest seller was Citigroup, cutting an estimated $41.4M.

  • 220 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $528M of ARK Genomic Revolution ETF stock for Q2 2025, up 9.5% quarter-over-quarter.
  • 36 funds opened new ARK Genomic Revolution ETF positions in Q2 2025 and 33 closed out, a net change of +3 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q2 2025 was JP Morgan Chase, an estimated $20.2M added.
  • The largest ARK Genomic Revolution ETF seller in Q2 2025 was Citigroup, an estimated $41.4M sold.

Based on aggregated 13F filings for Q2 2025.